Prescription drug prices
4 bills in the 2026 session, newest first.
Who lobbies on these bills
- Bristol Myers Squibb Co.0 for · 2 against
- Eli Lilly & Co.0 for · 2 against
- Genentech, Inc., A Member of the Roche Group0 for · 2 against
- Iowa Hospital Association2 for · 0 against
- Iowa Integrated Health Planning and Advisory Council2 for · 0 against
- Iowa Medical Society2 for · 0 against
- Iowa Pharmacy Association2 for · 0 against
- Iowa Primary Care Association2 for · 0 against
- Merck Sharp & Dohme LLC0 for · 2 against
- Novartis Services, Inc.0 for · 2 against
- Novo Nordisk0 for · 2 against
- Pharmaceutical Research and Manufacturers of America (PhRMA)0 for · 2 against
SF 2312 · Relating to manufacturers and distributors of 340B drugsDied when the session endedFebruary 12, 2026
SF 2322 · Relating to insurance coverage for prescription insulin drugsDied when the session endedFebruary 12, 2026
HF 2009 · Relating to manufacturers and distributors of 340B drugsDied when the session endedJanuary 21, 2026
SF 2047 · Relating to insurance coverage for prescription insulin drugsDied when the session endedJanuary 14, 2026